CLINICAL_TRIALS
research
· 2018-06-14
Clinical Trial Update: Risk Factors for Quinolone Resistance Among ESBL Producing Klebsiella Species
Summary
A completed clinical trial examining risk factors for quinolone resistance in ESBL-producing Klebsiella pneumoniae infections.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Pittsburgh | Conditions: Quinolone Resistance, ESBL | Status: COMPLETED